Role of angiotensin in body fluid homeostasis of mice: effect of losartan on water and NaCl intakes.
It is known that mice injected peripherally with ANG II do not show a drinking response but that cFos immunoreactivity (ir) is induced in brain regions similar to those in rats. We now show in Crl:CD1(ICR) mice that peripheral injection of the ANG II type 1 receptor antagonist losartan was sufficient to prevent this induction of Fos-ir in the subfornical organ (SFO). Injection of ANG II into the lateral cerebral ventricle produced a robust water intake in mice and induced Fos-ir in SFO, as well as in median preoptic (MnPO) and paraventricular (PVN) nuclei. Peripheral injection of losartan blocked this drinking response and prevented the induction of Fos-ir in each of these brain regions. Hypovolemia produced by polyethylene glycol (PEG) produced a robust water intake but no evidence of sodium appetite, and it induced Fos-ir in SFO, MnPO, and PVN. Peripheral injection of losartan did not affect this drinking response. Fos-ir induced by PEG in SFO and MnPO was reduced by treatment with losartan, while that induced in the PVN was further increased by losartan. Sodium depletion with furosemide and low-sodium diet produced a strong sodium appetite and induced Fos-ir in SFO and MnPO. Treatment with losartan completely blocked the sodium appetite, as well as the induction of Fos-ir in these brain regions. These data indicate that endogenous production of ANG II and action at forebrain receptors is critically involved in depletion-related sodium appetite in mice. The absence of an effect of losartan on PEG-induced drinking suggests the critical involvement of other factor(s) such as arterial or venous baroreceptor input, and we discuss how this factor could also explain why peripheral ANG II is not dipsogenic in mice.
Crews
Emily C
EC
Department of Psychology, University of Florida, P.O. Box 112250, Gainesville, FL 32611-2250, USA.
Rowland
Neil E
NE
D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D001066:Appetite / Q000187:drug effects*; D001826:Body Fluids / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D004039:Diet, Sodium-Restricted; D004326:Drinking / Q000187:drug effects*; D006706:Homeostasis / Q000502:physiology*; D020896:Hypovolemia / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D007276:Injections, Intraventricular; D007279:Injections, Subcutaneous; D019808:Losartan / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D011092:Polyethylene Glycols; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D012965:Sodium Chloride / Q000008:administration & dosage*
D016760:Proto-Oncogene Proteins c-fos; D000804:Angiotensin II; D011092:Polyethylene Glycols; D012965:Sodium Chloride; D019808:Losartan